Evidence map›Paper›PMID 31978347›Full record

ArticleCell2020

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

David P Nusinow, John Szpyt, Mahmoud Ghandi, Christopher M Rose, E Robert McDonald, Marian Kalocsay, Judit Jané-Valbuena, Ellen Gelfand, Devin K Schweppe, Mark Jedrychowski and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 617 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
617citing papers in PubMed, 1 pooled it
70.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

617 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,024 citations in OpenAlex.

  1. Pooled it
  2. MGCLSyn: multimodal graph contrastive learning for drug synergy prediction.Journal of computer-aided molecular design · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Mitochondrial depolarization stabilizes the vitamin BProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Dysregulated mScience advances · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

557 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

David P NusinowDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: david_nusinow@hms.harvard.edu.
John SzpytDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Mahmoud GhandiBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Christopher M RoseDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
E Robert McDonaldNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Marian KalocsayDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Judit Jané-ValbuenaBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Ellen GelfandBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Devin K SchweppeDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Mark JedrychowskiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Javad GoljiNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Dale A PorterNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Tomas RejtarNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Y Karen WangNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Gregory V KryukovBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Frank StegmeierNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Brian K EricksonDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Levi A GarrawayBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
William R SellersNovartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: steven_gygi@hms.harvard.edu.
Harvard University · USNovartis (United States) · USBroad Institute · US

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
NIGMS NIH HHS R01 GM067945
6 · The paper itself

Abstract

Proteins are essential agents of biological processes. To date, large-scale profiling of cell line collections including the Cancer Cell Line Encyclopedia (CCLE) has focused primarily on genetic information whereas deep interrogation of the proteome has remained out of reach. Here, we expand the CCLE through quantitative profiling of thousands of proteins by mass spectrometry across 375 cell lines from diverse lineages to reveal information undiscovered by DNA and RNA methods. We observe unexpected correlations within and between pathways that are largely absent from RNA. An analysis of microsatellite instable (MSI) cell lines reveals the dysregulation of specific protein complexes associated with surveillance of mutation and translation. These and other protein complexes were associated with sensitivity to knockdown of several different genes. These data in conjunction with the wider CCLE are a broad resource to explore cellular behavior and facilitate cancer research.

Indexed as

Cell Line, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMass SpectrometryMicrosatellite InstabilityMutationNeoplasmsProteomeProteomicsProteomecancer cell linesCCLEmicrosatellite instabilityMSIprotein expressionquantitative proteomicsRNA/Protein correlationsystems biologyTMT

Identifiers

PMID31978347
PMCPMC7339254
OpenAlexW3001475835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.